Literature DB >> 10406928

Mechanisms of chlorophyllin anticarcinogenesis: dose-responsive inhibition of aflatoxin uptake and biodistribution following oral co-administration in rainbow trout.

T Hayashi1, M Schimerlik, G Bailey.   

Abstract

Chlorophyllin (CHL) is a potent blocking agent against aflatoxin B(1) DNA adduction and tumorigenesis in the trout model, but mechanisms responsible for this chemoprotection in vivo are not well established. This study employed aflatoxin B(2) (AFB(2)), a structural analogue of AFB(1) that cannot be metabolized directly to the 8,9-exo-epoxide electrophile, to investigate CHL effects on carcinogen uptake and distribution kinetics following oral exposure in trout. CHL was shown to form an AFB(2) complex in vitro with a dissociation constant (K(d) = 1.92 +/- 0.13 microM) comparable to that with AFB(1). Following gavage, [(3)H]AFB(2) equivalents distributed rapidly from the stomach to other organs including blood, liver, and eventually to bile as a major repository. Bile was found to contain almost entirely parent AFB(2) 1 h after gavage, with a single metabolite dominating 3-24 h and an additional metabolite prominent by 48 h after gavage. Addition of sufficient CHL (>/=13.9 mM) to assure >99% complexation of AFB(2) (0.906 microM) in the gavage mix resulted in 80-90% reduction in AFB(2) equivalents in liver and bile 3 h after gavage. In three separate kinetic studies of up to 120 h postgavage, addition of >/=13.9 mM CHL to the gavage mix reproducibly and markedly delayed the rate of AFB(2) loss from stomach, retarded its appearance in blood, liver, and bile, and reduced peak AFB(2) concentrations in those tissues by up to 60%. Introduction of a food bolus immediately after gavage prolonged AFB(2) residence in stomach and intestine but did not abrogate the inhibitory effects of CHL on AFB(2) uptake and distribution. These results demonstrate that oral co-treatment with CHL under conditions where complex formation is initially assured, substantially reduces AFB(2) systemic uptake and target organ bioavailability in the trout. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10406928     DOI: 10.1006/taap.1999.8695

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  9 in total

1.  Cancer chemoprevention by dietary chlorophylls: a 12,000-animal dose-dose matrix biomarker and tumor study.

Authors:  Tammie J McQuistan; Michael T Simonich; M Margaret Pratt; Cliff B Pereira; Jerry D Hendricks; Roderick H Dashwood; David E Williams; George S Bailey
Journal:  Food Chem Toxicol       Date:  2011-11-03       Impact factor: 6.023

2.  Attenuation of acridine mutagen ICR-191--DNA interactions and DNA damage by the mutagen interceptor chlorophyllin.

Authors:  Monika Pietrzak; H Dorota Halicka; Zbigniew Wieczorek; Jolanta Wieczorek; Zbigniew Darzynkiewicz
Journal:  Biophys Chem       Date:  2008-03-30       Impact factor: 2.352

Review 3.  The rainbow trout liver cancer model: response to environmental chemicals and studies on promotion and chemoprevention.

Authors:  David E Williams
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2011-06-16       Impact factor: 3.228

4.  The Ability of Chlorophyll to Trap Carcinogen Aflatoxin B1: A Theoretical Approach.

Authors:  Alma Vázquez-Durán; Guillermo Téllez-Isaías; Maricarmen Hernández-Rodríguez; René Miranda Ruvalcaba; Joel Martínez; María Inés Nicolás-Vázquez; Juan Manuel Aceves-Hernández; Abraham Méndez-Albores
Journal:  Int J Mol Sci       Date:  2022-05-28       Impact factor: 6.208

5.  The "interceptor" properties of chlorophyllin measured within the three-component system: intercalator-DNA-chlorophyllin.

Authors:  Monika Pietrzak; Zbigniew Wieczorek; Jolanta Wieczorek; Zbigniew Darzynkiewicz
Journal:  Biophys Chem       Date:  2006-04-06       Impact factor: 2.352

6.  Interactions of chlorophyllin with acridine orange, quinacrine mustard and doxorubicin analyzed by light absorption and fluorescence spectroscopy.

Authors:  Monika Pietrzak; Zbigniew Wieczorek; Alicja Stachelska; Zbigniew Darzynkiewicz
Journal:  Biophys Chem       Date:  2003-05-01       Impact factor: 2.352

7.  Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B(1) pharmacokinetics in human volunteers.

Authors:  Carole Jubert; John Mata; Graham Bench; Roderick Dashwood; Cliff Pereira; William Tracewell; Kenneth Turteltaub; David Williams; George Bailey
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01

8.  Low-dose dietary chlorophyll inhibits multi-organ carcinogenesis in the rainbow trout.

Authors:  Michael T Simonich; Tammie McQuistan; Carole Jubert; Cliff Pereira; Jerry D Hendricks; Michael Schimerlik; Benzan Zhu; Roderick H Dashwood; David E Williams; George S Bailey
Journal:  Food Chem Toxicol       Date:  2007-11-04       Impact factor: 6.023

9.  Chlorophyllin significantly reduces benzo[a]pyrene-DNA adduct formation and alters cytochrome P450 1A1 and 1B1 expression and EROD activity in normal human mammary epithelial cells.

Authors:  Channa Keshava; Rao L Divi; Tracey L Einem; Diana L Richardson; Sarah L Leonard; Nagalakshmi Keshava; Miriam C Poirier; Ainsley Weston
Journal:  Environ Mol Mutagen       Date:  2009-03       Impact factor: 3.216

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.